18F-FDG-PET is not a useful tool for end-of-treatment response evaluation in peripheral T-cell lymphomas

¹⁸F-FDG-PET is not a useful tool for end-of-treatment response evaluation in peripheral T-cell lymphomas

^*Corresponding author for this work

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

Original language	English
Pages (from-to)	217
Number of pages	1
Journal	Nuclear Medicine Communications
Volume	37
Issue number	2
DOIs	https://doi.org/10.1097/MNM.0000000000000437
Publication status	Published - 2016

@article{68ccde9c266f4751b4b3d2cb31aa1233,

title = "18F-FDG-PET is not a useful tool for end-of-treatment response evaluation in peripheral T-cell lymphomas",

author = "Adams, \{Hugo J A\} and Kwee, \{Thomas C.\}",

year = "2016",

doi = "10.1097/MNM.0000000000000437",

language = "English",

volume = "37",

pages = "217",

journal = "Nuclear Medicine Communications",

issn = "0143-3636",

publisher = "Wolters Kluwer Health",

number = "2",

}

TY - JOUR

T1 - 18F-FDG-PET is not a useful tool for end-of-treatment response evaluation in peripheral T-cell lymphomas

AU - Adams, Hugo J A

AU - Kwee, Thomas C.

PY - 2016

Y1 - 2016

UR - https://www.scopus.com/pages/publications/84953277179

U2 - 10.1097/MNM.0000000000000437

DO - 10.1097/MNM.0000000000000437

M3 - Comment/Letter to the editor

C2 - 26695447

AN - SCOPUS:84953277179

SN - 0143-3636

VL - 37

SP - 217

JO - Nuclear Medicine Communications

JF - Nuclear Medicine Communications

IS - 2

ER -